Studies with Monopropionyl Erythromycin

Abstract

Get full access to this article

View all access options for this article.

References

Calesnick

(1959). Effectiveness of oral erythromycin propionate in commonly occurring infections. Antibiot. Ann., 1959–60, 819.

Clapper

W. E.

Mostyn

Meade

G. H.

(1960). An evaluation of erythromycin stearate and monopropionyl erythromycin in normal and hospitalised patients. Antibiot. Med., 7, 91.

Cronk

E. A.

Naumann

D. E.

(1960). The treatment of infections with erythromycin propionate. Antibiot. Med., 7, 182.

Forfar

J. O.

Maccabe

A. F.

(1957). Erythromycin: A review. Antibiot. et Chemother. (Basel), 4, 115.

Garrod

L. P.

(1957). The erythromycin group of antibiotics. Brit. med. J., 2, 57.

Geraci

J. E.

(1959). Antibiotic therapy for staphylococcal diseases. p. 29. New York: Medical Encyclopedia Inc.

Goodman

(1959). The chemotherapy of acute and chronic paediatric and geriatric infections: Panel discussion. Antibiot. Ann., 1959–60, 1009.

Grove

D. C.

Randall

W. A.

(1955). Assay methods of antibiotics: a laboratory manual, p. 96. New York: Medical Encyclopedia Inc.

Hall

G. A.

Roberts

C. E.

Perry

D. M.

Kirby

W. M. M.

(1960). Erythromycin stearate and erythromycin propionate: A comparison of blood levels obtained after oral administration. Antibiot. Med., 7, 231.

10.

Jones

W. F.

Jr. Nichols

R. L.

Finland

(1956). Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptomycin. Proc. Soc. exp. Biol. (N.Y.), 93, 388.

11.

Kunin

C. M.

Hirsch

H. A.

Finland

(1958). Absorption of erythromycin propionate and triacetyloleandomycin. Antibiot. Ann., 1958–59, 382.

12.

McGuire

J. M.

Bunch

R. L.

Anderson

R. C.

Boaz

H. E.

Flynn

E. H.

Powell

H. M.

Smith

J. W.

(1952). ‘Ilotycin’, a new antibiotic. Antibiot. and Chemother., 2, 281.

13.

Murphy

H. W.

(1953). Esters of erythromycin. I. Some water-insoluble substantially tasteless esters. Antibiot. Ann., 1953–54, 500.

14.

Needham

G. M.

Geraci

J. E.

(1956). Laboratory studies of oleandomycin. Antibiot. Med., 3, 334.

15.

Settel

(1960). Evaluation of erythromycin propionate (‘Ilosone’) in general practice. Antibiot. Med., 7, 193.

16.

Shubin

Rosen

J. C.

Cohen

M. A.

(1960). Clinical studies with erythromycin propionate in infections. Antibiot. Med., 7, 253.

17.

Smith

I. M.

Soderstrom

W. H.

(1959). Clinical experience with a new erythromycin derivative, erythromycin propionate. J. Amer. Med. Ass., 170, 184.

18.

Smit

J. W.

Dyke

R. W.

Griffith

R. S.

(1953). Absorption following oral administration. of erythromycin. J. Amer. Med. Ass., 151, 805.

19.

Stephens

V. C.

Conine

J. W.

(1958). Esters of erythromycin. III. Esters of low molecular weight aliphatic acids. Antibiot. Ann., 1958–59, 346.

20.

Sylvester

J. C.

Josselyn

L. E.

(1953). Absorption of erythromycin. II. Erythromycin stearate. Antibiot. and Chemother. 3. 930.